PAT CONNECT 2026: Register now!

08.12.2025

News

The PAT Connect Conference will take place in Badenweiler on March 10 and 11, 2026. It brings together experts in pharmaceutical process analytics from industry, science, and regulatory authorities.

Expand your network.

Program and registration

On March 12, you will have the opportunity to visit the Glatt Innovation Center in Weil-Haltingen.

The international conference expects 150 to 250 leading experts from industry, science, and government agencies to discuss the latest developments in process analytical technology (PAT). Special focus will be placed on AI applications, continuous production, and data analytics, supplemented by regulatory perspectives and practical examples from industry.

Meet the GMP Compliance Adviser

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.

The demo access is non-binding and ends automatically.

Test it now for free

You may also be interested in the following articles:

05.10.2026

Question of the Week

What are the Benefits and Limitations of Passive Temperature-Controlled Containers for Drug Transport?

Here's the answer:

Outsourced Activities in the GDP Environment Part II: Contractual Agreements

05.10.2026

LOGFILE Feature

Outsourced Activities in the GDP Environment Part II: Contractual Agreements

When outsourcing GDP activities, there is a need for concrete delimitation of responsibilities between a client and a contractor. Read more about the goals and the contents of a quality agreement in the following excerpt from GMP:KnowHow Pharmalogistics (GDP).

FDA: Adjustment of Nitrosamine Limits for Short-Term Use Medicines

02.10.2026

News

FDA: Adjustment of Nitrosamine Limits for Short-Term Use Medicines

The FDA has updated its recommendations on Acceptable Intake (AI) limits for nitrosamine impurities. Under certain conditions, the Agency now accepts a Less-Than-Lifetime (LTL) adjustment of AI limits for medicinal products that are not intended for lifetime use. This also represents an alignment with the LTL concept of ICH M7(R2).

Swissmedic: SMS Registration Becomes Prerequisite for GMP Certificates

02.10.2026

News

Swissmedic: SMS Registration Becomes Prerequisite for GMP Certificates

As of 15 November 2026, active substances must be registered in the EMA's Substance Management Services (SMS) database before Swissmedic can include them in establishment licences and GMP certificates for active substance manufacturers. The new requirement results from modifications to the EudraGMDP database.

02.10.2026

News

EMA: New Q&As for Biological Medicinal Products

The EMA has added a new section to its Q&As on biological medicinal products addressing medicinal products containing secretomes or extracellular vesicles (EVs) obtained from human or animal cells.

02.10.2026

News

EU: Council Adopts the Pharmaceutical Package

On 28 September 2026, the Council of the European Union adopted the EU pharmaceutical package, marking another important step in the legislative process for the comprehensive reform of EU pharmaceutical legislation.